Stock Price Quote

ALPHA DRUG INDIA LTD. (AMALGAMATED)

NSE : NABSE : 500006ISIN CODE : INE256B01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE38.650 (0 %)
PREV CLOSE ( ) 38.65
OPEN PRICE ( ) 38.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )38.00 39.75
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987
Management Info
G Narayana - Chairman Shalil Shroff - Managing Director
Registered Office

Address Villages Kolimajra & Samalheri ,Post Lalru,,
Patiala,
Punjab-140501

Phone 91-01762-275210/519

Email NA

Website www.alphadrug.com

Registrars Details
Not Available
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Dec 05 ANNUAL 05
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2766.40 (5.55%)
M.Cap ( in Cr)1694.45
Bharat Parenterals (BSE)
peergroup  1650.00 (6.65%)
M.Cap ( in Cr)931.15
Astrazeneca Pharma I (BSE)
peergroup  5338.90 (1.32%)
M.Cap ( in Cr)13260.00
Vimta Labs (BSE)
peergroup  572.60 (12.40%)
M.Cap ( in Cr)1265.94
Dr. Reddy's Lab (BSE)
peergroup  6007.85 (0.95%)
M.Cap ( in Cr)99862.42

Shareholding Pattern

No Data Found

About Alpha Drug India Ltd. (Amalgamated)

Alpha Drug India Ltd. (Amalgamated) was incorporated in the year 1987. Its today's share price is 38.65. Its current market capitalisation stands at Rs 29.31 Cr. In the latest quarter, company has reported Gross Sales of Rs. 288.42 Cr and Total Income of Rs.326.27 Cr. The company's management includes JH Bhambhani, KL Khurana, SS Tiwari, L Rajagopalan, Ajay Mahajan, Avtar Singh, Punit K Abrol, Jagdish R Naik, Shalil Shroff, G N Gupta, G Narayana.

It is listed on the BSE with a BSE Code of 500006 , NSE with an NSE Symbol of and ISIN of INE256B01026. It's Registered office is at Villages Kolimajra & Samalheri ,Post Lalru,Patiala-140501, Punjab. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are S Tandon & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.